BD

Babita Devi

Active Director Director DIN 09223359
DIN 09223359 First appointment Jul 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Babita Devi

Data last updated:

Babita Devi is a Director at Ishu Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Ishu Pharmaceuticals Private Limited reported revenue of ₹43,360 (FY 2025).

DIN 09223359
Primary Designation Director
Industry Trading
First Appointment 01 Jul 2021
Oldest Company Age 5 yrs
Largest company Ishu Pharmaceuticals Private Limited · ₹43,360 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ishu Pharmaceuticals Private Limited U51909MH2021PTC363111
Director01 Jul 20212021₹43,360 (FY 2025)Active

Board colleagues of Babita Devi

NameDINCompanyDesignation
Prashant Mishra10126654Ishu Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ishu Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Babita Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babita Devi

Babita Devi currently holds 1 directorship: Ishu Pharmaceuticals Private Limited (Director, since 01 Jul 2021, revenue ₹43,360 (FY 2025)).

Babita Devi was first appointed on 01 Jul 2021 as Director at Ishu Pharmaceuticals Private Limited.

The current boards of Babita Devi's companies include Prashant Mishra (Ishu Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available